Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment.

Chen YL, Lin HW, Sun NY, Yie JC, Hung HC, Chen CA, Sun WZ, Cheng WF.

Cancers (Basel). 2019 May 2;11(5). pii: E617. doi: 10.3390/cancers11050617.

2.

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models.

Killion EA, Wang J, Yie J, Shi SD, Bates D, Min X, Komorowski R, Hager T, Deng L, Atangan L, Lu SC, Kurzeja RJM, Sivits G, Lin J, Chen Q, Wang Z, Thibault SA, Abbott CM, Meng T, Clavette B, Murawsky CM, Foltz IN, Rottman JB, Hale C, Véniant MM, Lloyd DJ.

Sci Transl Med. 2018 Dec 19;10(472). pii: eaat3392. doi: 10.1126/scitranslmed.aat3392.

PMID:
30567927
3.

Erratum: Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15.

Hsu JY, Crawley S, Chen M, Ayupova DA, Lindhout DA, Higbee J, Kutach A, Joo W, Gao Z, Fu D, To C, Mondal K, Li B, Kekatpure A, Wang M, Laird T, Horner G, Chan J, McEntee M, Lopez M, Lakshminarasimhan D, White A, Wang SP, Yao J, Yie J, Matern H, Solloway M, Haldankar R, Parsons T, Tang J, Shen WD, Alice Chen Y, Tian H, Allan BB.

Nature. 2017 Nov 16;551(7680):398. doi: 10.1038/nature24481. Epub 2017 Nov 8.

PMID:
29144449
4.

Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15.

Hsu JY, Crawley S, Chen M, Ayupova DA, Lindhout DA, Higbee J, Kutach A, Joo W, Gao Z, Fu D, To C, Mondal K, Li B, Kekatpure A, Wang M, Laird T, Horner G, Chan J, McEntee M, Lopez M, Lakshminarasimhan D, White A, Wang SP, Yao J, Yie J, Matern H, Solloway M, Haldankar R, Parsons T, Tang J, Shen WD, Alice Chen Y, Tian H, Allan BB.

Nature. 2017 Oct 12;550(7675):255-259. doi: 10.1038/nature24042. Epub 2017 Sep 27. Erratum in: Nature. 2017 Nov 16;551(7680):398.

PMID:
28953886
5.

A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys.

Stanislaus S, Hecht R, Yie J, Hager T, Hall M, Spahr C, Wang W, Weiszmann J, Li Y, Deng L, Winters D, Smith S, Zhou L, Li Y, Véniant MM, Xu J.

Endocrinology. 2017 May 1;158(5):1314-1327. doi: 10.1210/en.2016-1917.

PMID:
28324011
6.

Mirtazapine, in orodispersible form, for patients with preoperative psychological distress: A pilot study.

Chou WH, Lin FS, Lin CP, Lin WY, Yie JC, Sun WZ.

Acta Anaesthesiol Taiwan. 2016 Mar;54(1):16-23. doi: 10.1016/j.aat.2015.12.002. Epub 2016 Feb 10.

7.

Non-intubated thoracoscopic surgery using internal intercostal nerve block, vagal block and targeted sedation.

Hung MH, Hsu HH, Chan KC, Chen KC, Yie JC, Cheng YJ, Chen JS.

Eur J Cardiothorac Surg. 2014 Oct;46(4):620-5. doi: 10.1093/ejcts/ezu054. Epub 2014 Feb 28.

PMID:
24585550
8.

Polyethylene glycol modified FGF21 engineered to maximize potency and minimize vacuole formation.

Xu J, Bussiere J, Yie J, Sickmier A, An P, Belouski E, Stanislaus S, Walker KW.

Bioconjug Chem. 2013 Jun 19;24(6):915-25. doi: 10.1021/bc300603k. Epub 2013 May 9.

PMID:
23594041
9.

Quadriplegia after off-pump coronary artery bypass surgery: look before you place the neck in an extended position.

Li CC, Yie JC, Lai CH, Hung MH.

J Cardiothorac Vasc Anesth. 2013 Apr;27(2):e16-7. doi: 10.1053/j.jvca.2012.11.012. No abstract available.

PMID:
23507022
10.

A novel approach to improve the function of FGF21.

Smith R, Duguay A, Weiszmann J, Stanislaus S, Belouski E, Cai L, Yie J, Xu J, Gupte J, Wu X, Li Y.

BioDrugs. 2013 Apr;27(2):159-66. doi: 10.1007/s40259-013-0013-x.

PMID:
23456652
11.

Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes.

Hecht R, Li YS, Sun J, Belouski E, Hall M, Hager T, Yie J, Wang W, Winters D, Smith S, Spahr C, Tam LT, Shen Z, Stanislaus S, Chinookoswong N, Lau Y, Sickmier A, Michaels ML, Boone T, Véniant MM, Xu J.

PLoS One. 2012;7(11):e49345. doi: 10.1371/journal.pone.0049345. Epub 2012 Nov 27.

12.

Patient-controlled analgesia (PCA) following video-assisted thoracoscopic lobectomy: comparison of epidural PCA and intravenous PCA.

Yie JC, Yang JT, Wu CY, Sun WZ, Cheng YJ.

Acta Anaesthesiol Taiwan. 2012 Sep;50(3):92-5. doi: 10.1016/j.aat.2012.08.004. Epub 2012 Sep 7.

13.

Streptococcus agalactiae infective endocarditis with large vegetation in a patient with underlying protein S deficiency.

Cheng HL, Lin WC, Shih PY, Huang CH, Hsu YC, Yie JC, Chen SY, Lin CP.

Infection. 2013 Feb;41(1):247-50. doi: 10.1007/s15010-012-0334-6. Epub 2012 Sep 22.

PMID:
23001489
14.

Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling.

Yie J, Wang W, Deng L, Tam LT, Stevens J, Chen MM, Li Y, Xu J, Lindberg R, Hecht R, Véniant M, Chen C, Wang M.

Chem Biol Drug Des. 2012 Apr;79(4):398-410. doi: 10.1111/j.1747-0285.2012.01325.x. Epub 2012 Feb 1.

PMID:
22248288
15.

FGF21 N- and C-termini play different roles in receptor interaction and activation.

Yie J, Hecht R, Patel J, Stevens J, Wang W, Hawkins N, Steavenson S, Smith S, Winters D, Fisher S, Cai L, Belouski E, Chen C, Michaels ML, Li YS, Lindberg R, Wang M, Véniant M, Xu J.

FEBS Lett. 2009 Jan 5;583(1):19-24. doi: 10.1016/j.febslet.2008.11.023. Epub 2008 Dec 4.

16.

Pharmacological characterization of a small molecule inhibitor of c-Jun kinase.

Cho H, Black SC, Looper D, Shi M, Kelly-Sullivan D, Timofeevski S, Siegel K, Yu XH, McDonnell SR, Chen P, Yie J, Ogilvie KM, Fraser J, Briscoe CP.

Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1142-51. doi: 10.1152/ajpendo.90298.2008. Epub 2008 Aug 26.

17.

Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis.

Vera-Portocarrero LP, Xie JY, Kowal J, Ossipov MH, King T, Porreca F.

Gastroenterology. 2006 Jun;130(7):2155-64. Erratum in: Gastroenterology. 2006 Sep;131(3):979. Yie, Jennifer X [corrected to Xie, Jennifer Y].

PMID:
16762636
18.

Rational design of ordered mesoporous carbon with controlled bimodal porosity via dual silica templating route.

Lee HI, Pak C, Shin CH, Chang H, Seung D, Yie JE, Kim JM.

Chem Commun (Camb). 2005 Dec 28;(48):6035-7. Epub 2005 Nov 8.

PMID:
16333519
19.

Role of copper chloride on the surface of activated carbon in adsorption of methyl mercaptan.

Kim DJ, Yie JE.

J Colloid Interface Sci. 2005 Mar 15;283(2):311-5.

PMID:
15721899
20.

Dehydroxylation route to surface modification of mesoporous silicas by using grignard reagents.

Lim JE, Shim CB, Kim JM, Lee BY, Yie JE.

Angew Chem Int Ed Engl. 2004 Jul 19;43(29):3839-42. No abstract available.

PMID:
15258950
21.

Direct synthesis of ordered mesoporous materials constructed with polymer-silica hybrid frameworks.

Kang YS, Lee HI, Zhang Y, Han YJ, Yie JE, Stucky GD, Kim JM.

Chem Commun (Camb). 2004 Jul 7;(13):1524-5. Epub 2004 May 25.

PMID:
15216362
22.

Adsorption and conversion of various hydrocarbons on monolithic hydrocarbon adsorber.

Kim DJ, Kim JM, Yie JE, Seo SG, Kim SC.

J Colloid Interface Sci. 2004 Jun 15;274(2):538-42.

PMID:
15144827
23.

Highly stable mesoporous metal oxides using nano-propping hybrid gemini surfactants.

Lyu YY, Yi SH, Shon JK, Chang S, Pu LS, Lee SY, Yie JE, Char K, Stucky GD, Kim JM.

J Am Chem Soc. 2004 Mar 3;126(8):2310-1.

PMID:
14982427
24.

[Antibiotic resistance and plasmid profiles of Vibrio isolates from cultured Sparus sarba].

Li J, Yie J, Fu W, Foo RW, Hu Y, Woo NY, Xu H.

Wei Sheng Wu Xue Bao. 1999 Oct;39(5):461-8. Chinese.

PMID:
12555529
25.

Reversible replication between ordered mesoporous silica and mesoporous carbon.

Kang M, Yi SH, Lee HI, Yie JE, Kim JM.

Chem Commun (Camb). 2002 Sep 7;(17):1944-5.

PMID:
12271686
26.

Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms.

Mueller E, Drori S, Aiyer A, Yie J, Sarraf P, Chen H, Hauser S, Rosen ED, Ge K, Roeder RG, Spiegelman BM.

J Biol Chem. 2002 Nov 1;277(44):41925-30. Epub 2002 Aug 27.

27.

Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter.

Agalioti T, Lomvardas S, Parekh B, Yie J, Maniatis T, Thanos D.

Cell. 2000 Nov 10;103(4):667-78.

28.

Gene repression by coactivator repulsion.

Senger K, Merika M, Agalioti T, Yie J, Escalante CR, Chen G, Aggarwal AK, Thanos D.

Mol Cell. 2000 Oct;6(4):931-7.

29.

Mechanism by which the IFN-beta enhanceosome activates transcription.

Yie J, Senger K, Thanos D.

Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13108-13.

30.

The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.

Yie J, Merika M, Munshi N, Chen G, Thanos D.

EMBO J. 1999 Jun 1;18(11):3074-89.

31.

Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome.

Munshi N, Merika M, Yie J, Senger K, Chen G, Thanos D.

Mol Cell. 1998 Oct;2(4):457-67.

32.

Structure of IRF-1 with bound DNA reveals determinants of interferon regulation.

Escalante CR, Yie J, Thanos D, Aggarwal AK.

Nature. 1998 Jan 1;391(6662):103-6.

PMID:
9422515
33.

Expression, purification, and co-crystallization of IRF-I bound to the interferon-beta element PRDI.

Escalante CR, Yie J, Thanos D, Aggarwal AK.

FEBS Lett. 1997 Sep 8;414(2):219-20.

34.
35.

Supplemental Content

Support Center